Key result
Visceral fat area was significantly associated with diabetic retinopathy in individuals with longstanding type 2 diabetes (OR 1.060; 95% CI 1.004-1.119; p=0.035), though mediated by renal burden.
Why the study?
Is visceral adiposity associated with diabetic retinopathy in individuals with longstanding type 2 diabetes?
Cross-Sectional (n=953)
Is visceral adiposity associated with diabetic retinopathy in individuals with longstanding type 2 diabetes?
Odds Ratio: 1.06 (95% CI 1.004–1.119)
p-value: p=0.035
Visceral adiposity is associated with diabetic retinopathy in longstanding type 2 diabetes, a relationship that appears to be largely mediated by coexisting renal burden.
May inform retinopathy risk stratification in longstanding type 2 diabetes; leaves open independent causal role beyond renal mediation.
Purpose/Aim: Diabetic retinopathy (DR) is the most common diabetic microvascular complication, and it typically develops after 10 years of diabetes diagnosis. The primary aim of this study was to evaluate the association between adiposity and DR susceptibility among individuals with longstanding type 2 diabetes mellitus (T2D). MATERIALS AND METHODS: In this cross-sectional study, DR was assessed by fundus photography in 953 T2D subjects. DR prevalence by categories of T2D duration was evaluated. In a sub-cohort analysis, subjects having T2D for ≥10 years were divided into DR (N = 241) and non-DR (N = 377) groups. Measures of adiposity including body mass index (BMI), waist circumference (WC), and visceral fat area (VFA) were analyzed. Urinary albumin:creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) were measured. RESULTS: DR prevalence markedly increased 10 years after T2D diagnosis (p < 0.001). Among subjects with T2D duration ≥10 years, BMI, WC, and VFA were elevated in DR compared with non-DR (all p < 0.05). Contrasting with BMI and WC, the association between VFA and DR sustained adjustment for demographics, metabolic factors, and insulin treatment (OR: 1.060, 95% CI: 1.004-1.119, p = 0.035). However, the association became insignificant after controlling for ACR and eGFR. Mediation analysis revealed that ACR and eGFR explained 47.3% of the relationship between VFA and DR. CONCLUSIONS: The findings suggest that visceral adiposity is associated with DR in individuals with longstanding T2D. This relationship may be attributable to generalized vascular injury as reflected by coexisting renal burden. Therefore, effective management of visceral adiposity and ameliorating renal burden may ameliorate susceptibility to DR.
No takes yet. Share an insight, caveat, or question.
Moh et al. (2018) conducted a cross-sectional in Type 2 diabetes mellitus (n=953). Visceral adiposity (visceral fat area) was evaluated on Diabetic retinopathy (OR 1.060, 95% CI 1.004-1.119, p=0.035). Visceral fat area was significantly associated with diabetic retinopathy in individuals with longstanding type 2 diabetes (OR 1.060; 95% CI 1.004-1.119; p=0.035), though mediated by renal burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: